New and updated preclinical and clinical data presented by biopharma firms at the American Society of Clinical Oncology annual meeting, including: Adicet, Akeso, Alphamab, Amgen, Anheart, Arcellx, Astrazeneca, Atara, Aveo, Ayala, Biontech, BMS, Carsgen, Centessa, Clovis, CG, Corcept, Cstone, Curis, Cyteir, Effector, Eisai, Enterome, Gilead, Henlius, Immunocore, Immutep, In8bio, Innovent, Intensity, Jacobio, Janssen, JW, Kite, Legend, Linnaeus, Mei, Menarini, Merck, Mirati, Nanobiotix.